These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33148665)

  • 1. Rheumatologists' perspective on hydroxychloroquine guidelines.
    Winebrake J; Khalili L; Weiner J; Gartshteyn Y; Park L; Askanase AD
    Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33148665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.
    Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D
    Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
    AlAhmed O; Way A; Akoghlanian S; Barbar-Smiley F; Lemle S; MacDonald D; Frost E; Wise K; Lee L; Ardoin SP; Sivaraman V
    Lupus; 2021 Feb; 30(2):269-279. PubMed ID: 33307983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologists' and Rheumatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study.
    Alghamdi AS; AlQefari GB; Alduraibi K; Al-Amer M; Alharbi BA; Alqefari AN; Alqifari HN; Alhameedy MM
    Cureus; 2024 Mar; 16(3):e56179. PubMed ID: 38618426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Hydroxychloroquine Dosing Guidelines by Rheumatologists: An Electronic Medical Record-Based Study in an Integrated Health Care System.
    Braslow RA; Shiloach M; Macsai MS
    Ophthalmology; 2017 May; 124(5):604-608. PubMed ID: 28153440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle.
    Overbury RS; Stoddard GJ; Pupaibool J; Hansen CB; Lebiedz-Odrobina D
    BMC Health Serv Res; 2021 Sep; 21(1):913. PubMed ID: 34479563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
    Pedrosa T; Kupa LVK; Pasoto SG; Aikawa NE; Borba EF; Duarte NJ; Leon EP; Silva CA; Bonfá E
    Lupus; 2021 Apr; 30(4):554-559. PubMed ID: 33402039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
    Zanetti CB; Pedrosa T; Kupa LVK; Aikawa NE; Borba EF; Vendramini MBG; Silva CA; Pasoto SG; Bonfa E
    Clin Rheumatol; 2021 Jul; 40(7):2745-2751. PubMed ID: 33486596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Systemic Lupus Erythematosus and Rheumatoid Arthritis: Results of a Quality Improvement Initiative.
    Skorupa T; Shmerling RH
    ACR Open Rheumatol; 2021 Oct; 3(10):733-737. PubMed ID: 34363746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus.
    Lee JE; Nam DR; Sung YK; Kim YJ; Jung SY
    Sci Rep; 2023 May; 13(1):7270. PubMed ID: 37142639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.
    Osmani Z; Schrama TJ; Zacouris-Verweij W; Andersen J; Frankel S; Bultink IEM; Cornet A; van Vollenhoven RF
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33795484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
    Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
    Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
    Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatologists' attitudes toward routine screening for hydroxychloroquine retinopathy.
    Fraenkel L; Felson DT
    J Rheumatol; 2001 Jun; 28(6):1218-21. PubMed ID: 11409112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
    Browning DJ; Yokogawa N; Greenberg PB; Perlman E
    Am J Ophthalmol; 2020 Nov; 219():101-106. PubMed ID: 32610049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.
    Petri M; Elkhalifa M; Li J; Magder LS; Goldman DW
    Arthritis Rheumatol; 2020 Mar; 72(3):448-453. PubMed ID: 31532077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
    J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.